Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Parkinson's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    October 2025
  1. CHAHRA C, Sawssen M, Anis H, Salma N, et al
    Randomized, placebo-controlled pilot study of Origanum majorana tea on oxidant/antioxidant stress biomarkers in Parkinson's idiopathic disease: a randomized controlled pilot Tunisian study.
    Neuroscience. 2025 Oct 4:S0306-4522(25)00977.
    PubMed     Abstract available


    September 2025
  2. MADHUSUDHAN K, Padmanaban A, Parvathi VD
    Early detection of Parkinson's disease via aptamer-CRISPR platform.
    Neuroscience. 2025 Sep 20:S0306-4522(25)00951.
    PubMed     Abstract available


  3. BAO W, Ge Y, Huang J, Li Y, et al
    DJ-1/PARK7 in Parkinson's disease: mechanisms of pathogenesis and therapeutic potential.
    Neuroscience. 2025 Sep 19:S0306-4522(25)00949.
    PubMed     Abstract available


  4. SINGH H, Kumari S, Taliyan R
    Epigenetic mechanisms linking environmental exposure to Parkinson's disease: A comprehensive review.
    Neuroscience. 2025;585:367-380.
    PubMed     Abstract available


  5. ZHIDAN L, Xianjie L, Shulin S, Qiang J, et al
    TREM2 mediates parkinsonism-like neurodegeneration in carbon disulfide-induced neurotoxicity.
    Neuroscience. 2025;585:50-59.
    PubMed     Abstract available


    August 2025
  6. ATANASOVSKI D, Bergquist F, Eriksson E, Carlsson T, et al
    The dopamine stabilizer (-)-OSU6162 attenuates levodopa-induced dyskinesia in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Neuroscience. 2025 Aug 23:S0306-4522(25)00889.
    PubMed     Abstract available


  7. DA SILVA CHAAR NETA R, da Silva Batista C, Machado Palmerim EM, Costa Dias HM, et al
    The impact of social isolation due to the COVID-19 pandemic on functional performance, fall risk, and gait in individuals with Parkinson's Disease: a systematic review.
    Neuroscience. 2025;584:113-126.
    PubMed     Abstract available


  8. GWEDELA MNV, Gadama Y, Phiri TE
    Parkinson's disease in Malawi: A cross-sectional Study of clinical profiles and risk factors.
    Neuroscience. 2025;584:88-92.
    PubMed     Abstract available


    July 2025
  9. WANG B, Zhao Z, Guo RN, Wu X, et al
    Enhanced focality and intensity in deep brain targeting: In silico study on multi-channel temporal interference stimulation for Parkinson's disease.
    Neuroscience. 2025;582:72-81.
    PubMed     Abstract available


  10. SONG J, Wang X, Dong L, Hui S, et al
    Identification of differentially co-expressed genes with lipid metabolism in Parkinson's disease by bioinformatics analysis.
    Neuroscience. 2025;581:58-71.
    PubMed     Abstract available


  11. YADAV S, Raj RG
    Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons.
    Neuroscience. 2025;581:1-15.
    PubMed     Abstract available


    June 2025
  12. WANG Z, Liu Y, Li C, Qin K, et al
    Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease.
    Neuroscience. 2025;580:306-314.
    PubMed     Abstract available


  13. HU L, Han J, Ma R, Cheng J, et al
    Cathodal high-definition transcranial direct current stimulation improves sleep and motor symptoms in Parkinson's disease with possible rapid eye movement sleep behaviors disorder: A pilot open-label study.
    Neuroscience. 2025 Jun 27:S0306-4522(25)00738.
    PubMed     Abstract available


  14. ZABALA-GOMEZ O, Ibarretxe-Bilbao N, Tijero B, Gabilondo I, et al
    Fatigue brain network functional connectivity in Parkinson's disease.
    Neuroscience. 2025 Jun 3:S0306-4522(25)00674.
    PubMed     Abstract available


    May 2025
  15. CHEN D, Jiang Y, Ge F, Liu X, et al
    High-frequency repetitive transcranial magnetic stimulation upregulates BDNF expression and promotes synaptogenesis in mouse models of Parkinson's disease.
    Neuroscience. 2025 May 30:S0306-4522(25)00671.
    PubMed     Abstract available


  16. KUANG Z, Huang X, Wang M, Bu S, et al
    Thalamic free water elevation and its association with glymphatic dysfunction in Parkinson's disease: A cross-sectional and longitudinal study.
    Neuroscience. 2025 May 27:S0306-4522(25)00667.
    PubMed     Abstract available


  17. QIN K, Liu Y, Xue L, Li H, et al
    Resting-state fMRI study on male patients with Parkinson's disease and with sexual dysfunction.
    Neuroscience. 2025 May 19:S0306-4522(25)00392.
    PubMed     Abstract available


  18. GLASBAUER ND, Sookoian S, Pirola CJ
    Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.
    Neuroscience. 2025 May 19:S0306-4522(25)00393.
    PubMed     Abstract available


  19. RUST C, van den Heuvel LL, Bardien S, Carr J, et al
    Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson's disease.
    Neuroscience. 2025;576:149-154.
    PubMed     Abstract available


    April 2025
  20. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025 Apr 17:S0306-4522(25)00224.
    PubMed    


  21. PARACKA L, Heldmann M, Lange F, Saryyeva A, et al
    Subthalamic nucleus dynamics during executive functioning: Insights from local field potentials in Parkinson's disease.
    Neuroscience. 2025 Apr 8:S0306-4522(25)00283.
    PubMed     Abstract available


  22. MEHREEN M, Ali M, Tariq H, Noor A, et al
    Chenodeoxycholic Acid-Mediated neuroprotection via alpha-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson's disease.
    Neuroscience. 2025;573:442-450.
    PubMed     Abstract available


    March 2025
  23. LAU F, Binacchi R, Brugnara S, Cumplido-Mayoral A, et al
    Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease.
    Neuroscience. 2025 Mar 26:S0306-4522(25)00244.
    PubMed     Abstract available


  24. SHARMA V, Unjum Saqib BZ, Aran KR
    Leptin as a potential neuroprotective target in Parkinson's Disease: Exploring its role in Neuroinflammation, oxidative Stress, and dopaminergic neurodegeneration.
    Neuroscience. 2025;572:134-144.
    PubMed     Abstract available


  25. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025;571:31.
    PubMed    


    February 2025
  26. ZHANG T, Jin Z, Chen K, Pei G, et al
    Characteristics of multimodal physiological signal differences in symptom fluctuations in Parkinson's disease.
    Neuroscience. 2025;569:322-330.
    PubMed     Abstract available


    January 2025
  27. ZUO Y, Ding X, Liu Z, Xie Y, et al
    Diverse pathways for the treatment of Parkinson's disease: Integration and development of traditional and emerging therapies.
    Neuroscience. 2025 Jan 26:S0306-4522(25)00057.
    PubMed     Abstract available


  28. ZHENG D, Chen J
    MicroRNAs in Parkinson's disease: From pathogenesis to diagnostics and therapeutic strategies.
    Neuroscience. 2025;568:298-313.
    PubMed     Abstract available


  29. BERGAMINO M, Fuentes A, Sandoval IM, Marmion DJ, et al
    Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2025;568:2-11.
    PubMed     Abstract available


  30. LIU M, Wang J, Wang R, Sun F, et al
    MRI evaluation of neuroprotective effects of Astragaloside ? on rotenone-induced late-stage Parkinson's disease mice.
    Neuroscience. 2025 Jan 4:S0306-4522(24)00753.
    PubMed     Abstract available


    December 2024
  31. YIN N, Li P, Li X, Li X, et al
    Increased alpha-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease.
    Neuroscience. 2024 Dec 30:S0306-4522(24)00763.
    PubMed     Abstract available


  32. DWIVEDI A, Kumar A, Faruq M, Singh VK, et al
    Co-occurrence of Parkinson's disease and Retinitis Pigmentosa: A genetic and in silico analysis.
    Neuroscience. 2024;565:519-526.
    PubMed     Abstract available


  33. ABSALYAMOVA M, Traktirov D, Burdinskaya V, Artemova V, et al
    Molecular basis of the development of Parkinson's disease.
    Neuroscience. 2024;565:292-300.
    PubMed     Abstract available


    November 2024
  34. XIAO K, Li J, Zhou L, Liu X, et al
    Retinopathy in Parkinson's disease: A potential biomarker for early diagnosis and clinical assessment.
    Neuroscience. 2024 Nov 29:S0306-4522(24)00692.
    PubMed     Abstract available


  35. ZHAO X, Xiao P, Gui H, Xu B, et al
    Combined graph convolutional networks with a multi-connection pattern to identify tremor-dominant Parkinson's disease and Essential tremor with resting tremor.
    Neuroscience. 2024;563:239-251.
    PubMed     Abstract available


  36. LI H, Li C, Ma W, Qin K, et al
    Eye movement disorders: A new approach to preliminary screening of Parkinson's disease.
    Neuroscience. 2024;563:202-211.
    PubMed     Abstract available


  37. MI X, Li M, Zhang Y, Qu L, et al
    Intracerebroventricular injection of alpha-synuclein preformed fibrils do not induce motor and olfactory impairment in C57BL/6 mice.
    Neuroscience. 2024;559:293-301.
    PubMed     Abstract available


  38. YUAN J, Dong X, Zhou S, Nao J, et al
    Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.
    Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
    PubMed     Abstract available


    October 2024
  39. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Corrigendum to "Assessing the location, relative expression and subclass of dopamine receptors in the cerebellum of hemi-parkinsonian rats" [Neuroscience 521 (2023) 1-19].
    Neuroscience. 2024 Oct 25:S0306-4522(24)00561.
    PubMed    


  40. LIANG X, Wen Y, Feng C, Xu L, et al
    Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10.
    Neuroscience. 2024;562:43-53.
    PubMed     Abstract available


  41. LEE HM, Lee DH, Lee HG, Kwon S, et al
    Functional neural substrates of Parkinson's disease and potential underpinnings of acute responses to acupuncture stimulation.
    Neuroscience. 2024 Oct 22:S0306-4522(24)00534.
    PubMed     Abstract available


    September 2024
  42. MAO Z, Zhang Y, Liang Y, Xia C, et al
    Liver?X?receptor alpha contribution to neuroinflammation and glial cells activation induced by MPTP: Implications for Parkinson's disease.
    Neuroscience. 2024 Sep 19:S0306-4522(24)00485.
    PubMed     Abstract available


  43. KUMAR BEURA S, Yadav P, Ramachandra Panigrahi A, Sahoo G, et al
    Impact of 6-Hydroxydopamine on Agonist-Induced human platelet functional Parameters: An explanation for platelet impairment in Parkinson's disease.
    Neuroscience. 2024 Sep 9:S0306-4522(24)00466.
    PubMed     Abstract available


    August 2024
  44. CIERI F, Giriprakash PP, Nandy R, Zhuang X, et al
    Functional connectivity differences of the olfactory network in Parkinson's Disease, mild cognitive impairment and cognitively normal individuals: A resting-state fMRI study.
    Neuroscience. 2024 Aug 21:S0306-4522(24)00428.
    PubMed     Abstract available


  45. MEILAN S, Song W, Oumei C, Kai X, et al
    Constipation is associated with emotional and cognitive impairment in patients with Parkinson's disease: a clinical and brain functional study.
    Neuroscience. 2024 Aug 19:S0306-4522(24)00413.
    PubMed     Abstract available


  46. LUO H, Yu X, Li P, Hu J, et al
    Different neurotoxicity and seeding activity between alpha-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.
    Neuroscience. 2024;557:1-11.
    PubMed     Abstract available


    July 2024
  47. DUNCAN SJ, Marques K, Fawkes J, Smith LJ, et al
    Galvanic Vestibular Stimulation Modulates EEG Markers of Voluntary Movement in Parkinson's Disease.
    Neuroscience. 2024 Jul 27:S0306-4522(24)00368.
    PubMed     Abstract available


  48. ANANDHAN A, Janakiraman U, Manivasagam T
    RETRACTED: "Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease" [Neurosci. 218 (2012) 25
    Neuroscience. 2024 Jul 26:S0306-4522(24)00365.
    PubMed    


  49. LIU T, Li J, Sun L, Zhu C, et al
    The role of ACE2 in RAS axis on microglia activation in Parkinson's disease.
    Neuroscience. 2024 Jul 8:S0306-4522(24)00281.
    PubMed     Abstract available


    June 2024
  50. HUANG M, Yu H, Lyu X, Pu W, et al
    Region-specific cerebral metabolic alterations in Parkinson's disease patients with/without mild cognitive impairment.
    Neuroscience. 2024 Jun 5:S0306-4522(24)00241.
    PubMed     Abstract available


  51. KUMARI S, Rana B, Senthil Kumaran S, Chaudhary S, et al
    Gray matter atrophy in a 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2024 Jun 4:S0306-4522(24)00229.
    PubMed     Abstract available


    May 2024
  52. DA SILVA OLIVEIRA B, Cristina de Brito Toscano E, Katharina Sabino Abreua L, de Barros Fernandes H, et al
    Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.
    Neuroscience. 2024 May 13:S0306-4522(24)00205.
    PubMed     Abstract available


  53. HUANG W, Zhang T, Li X, Gong L, et al
    Intranasal administration of umbilical cord mesenchymal stem cell exosomes alleviates Parkinson's disease.
    Neuroscience. 2024 May 3:S0306-4522(24)00169.
    PubMed     Abstract available


    April 2024
  54. FASCIANI I, Petragnano F, Bono F, Aloisi G, et al
    In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons.
    Neuroscience. 2024;544:104-116.
    PubMed     Abstract available


    March 2024
  55. SALLY SAMSON J, Ramesh A, Deepa Parvathi V
    Development of midbrain dopaminergic neurons and the advantage of using hiPSCs as a model system to study Parkinson's disease.
    Neuroscience. 2024 Mar 22:S0306-4522(24)00138.
    PubMed     Abstract available


  56. DENG HW, Li BR, Zhou SD, Luo C, et al
    Revealing Novel Genes Related to Parkinson's Disease Pathogenesis and Establishing an associated Model.
    Neuroscience. 2024;544:64-74.
    PubMed     Abstract available


  57. ZHU D, Zhang S, Wang X, Xiao C, et al
    Secretory Clusterin Inhibits Dopamine Neuron Apoptosis in MPTP Mice by Preserving Autophagy Activity.
    Neuroscience. 2024;540:38-47.
    PubMed     Abstract available


    November 2023
  58. MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al
    Heat Shock Protein 90 in Parkinson's disease: Profile of a serial killer.
    Neuroscience. 2023 Nov 29:S0306-4522(23)00532.
    PubMed     Abstract available


    October 2023
  59. SUBRAMANIYAN S, Briget Kuriakose B, Mushfiq S, Marimuthu Prabhu N, et al
    Gene signals and SNPs associated with Parkinson's disease: A nutrigenomics and computational prospective insights.
    Neuroscience. 2023 Oct 17:S0306-4522(23)00457.
    PubMed     Abstract available


  60. DZOLJIC E, Saric Matutinovic M, Stojkovic O, Velickovic J, et al
    Vitamin D serum levels and vitamin D receptor genotype in patients with Parkinson's disease.
    Neuroscience. 2023 Oct 11:S0306-4522(23)00454.
    PubMed     Abstract available


    September 2023
  61. HUANG J, Yuan X, Chen L, Hu B, et al
    The biology, pathological roles of exosomes and their clinical application in Parkinson(')s disease.
    Neuroscience. 2023 Sep 7:S0306-4522(23)00409.
    PubMed     Abstract available


    July 2023
  62. ZHOU L, Li Y, Wang M, Han W, et al
    Disruption of alpha-Synuclein Proteostasis in the Striatum and Midbrain of Long-term Ovariectomized Female Mice.
    Neuroscience. 2023;523:80-90.
    PubMed     Abstract available


  63. YUAN Y, Zhang X, Wu Y, Lian P, et al
    ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage.
    Neuroscience. 2023;523:61-79.
    PubMed     Abstract available


    June 2023
  64. PEDRO AMORIM NETO D, Vitor Pereira de Godoy J, Tostes K, Pelegrini Bosque B, et al
    Metabolic disturbances in the gut-brain axis of a mouse model of MPTP-induced Parkinsonism evaluated by Nuclear Magnetic Resonance.
    Neuroscience. 2023 Jun 16:S0306-4522(23)00266.
    PubMed     Abstract available


  65. PU Z, Liu S, Guo Z, Zhang X, et al
    Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Neuroscience. 2023 Jun 13:S0306-4522(23)00225.
    PubMed     Abstract available


    April 2023
  66. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Assessing the Location, Relative Expression and Subclass of Dopamine Receptors in the Cerebellum of Hemi-Parkinsonian Rats.
    Neuroscience. 2023 Apr 26:S0306-4522(23)00143.
    PubMed     Abstract available


    March 2023
  67. KANDIL EA, Abdelkader NF, El-Sayeh BM, Saleh S, et al
    Corrigendum to "Imipramine and Amitriptyline Ameliorate the Rotenone Model of Parkinson's Disease in Rats" [Neuroscience 332 (2016) 26-37].
    Neuroscience. 2023 Mar 6:S0306-4522(23)00120.
    PubMed    


    February 2023
  68. LOU T, Tao B, Chen M
    Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
    Neuroscience. 2023 Feb 2:S0306-4522(23)00055.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.